Zandelisib

Zandelisib is an investigational new drug that is being evaluated to treat follicular lymphoma.[1] It is a phosphatidylinositol 3 kinase delta inhibitor.[2]

## References

1. ↑ "Zandelisib - MEI Pharma/Kyowa Kirin". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800038809.
2. ↑ "PI3K Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Current Status and Future Perspectives". Cancers 14 (6): 1571. March 2022. doi:10.3390/cancers14061571. PMID 35326722.

0.00

(0 votes)

Original source: https://en.wikipedia.org/wiki/Zandelisib. Read more

|

Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:Zandelisib&oldid=4027562"